FDA Brief

Warning letters Food

FDA warning letter to

Allimax Us

High riskIssued Jan 12, 2021Posted Jan 27, 2021Center for Food Safety and Applied Nutrition (CFSAN)

Allimax US sold allicin products as unapproved COVID-19 drugs with unlawful labeling.

What happened

FDA reviewed www.allimax.us on November 17, 2020, and FTC reviewed it on December 15, 2020; FDA also reviewed the company’s Facebook and Instagram pages. The letter cites website and social media claims that allicin capsules, creams, gels, sprays, and liquids could mitigate, prevent, treat, diagnose, or cure COVID-19. FDA says these claims make the products unapproved new drugs and misbranded drugs.

What FDA found

  1. The company sold allicin products with COVID-19 claims without the FDA approval required for a new drug.

    section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)
  2. The products were misbranded, meaning their labeling broke drug law, because they made unapproved COVID-19 claims.

    section 502 of the FD&C Act, 21 U.S.C. § 352
  3. The company introduced or delivered these products for introduction into interstate commerce.

    sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
  4. The company advertised that its products can prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.

    FTC Act, 15 U.S.C. 41 et seq.

What FDA wants

FDA tells the company to stop selling these products for COVID-19 and, within 48 hours, email FDA with the specific corrective steps, how it will prevent repeat violations, and supporting documents. FTC also asks for an email within 48 hours describing actions taken.

Who should pay attention

  • online sellers of herbal or supplement products
  • companies making immune-support or antiviral claims
  • brands promoting products on social media

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.

    FDA says Medolife sold unapproved Escozine drugs online with claims to treat cancer, HIV, and COVID-19.

    High risk
  2. www.ivermectin4covid.com

    FDA warned website ivermectin4covid.com for selling unapproved, misbranded ivermectin drugs claiming COVID-19 use.

    High risk
  3. Medical Mikes, Inc.

    FDA and FTC warned Medical Mikes over unapproved CBD claims to prevent or treat COVID-19.

    High risk
  4. Purecraft LLC

    FDA and FTC warn Purecraft LLC over CBD products marketed with unapproved COVID-19 prevention and treatment claims.

    High risk